Calhoun Lesley Ann — SEC Form 4 filings
SEC reporting owner CIK 1730866. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-28 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,000 shares, $36,039 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 5,000 shares @ $7.21 ($36,039) in Tango Therapeutics, Inc., filed 2024-06-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tango Therapeutics, Inc. (TNGX) | Director | 3 | — | 1 leg · 5,000 sh · $36,039 | 6 |
| Aligos Therapeutics, Inc. (ALGS) | See Remarks | 6 | — | — | 11 |
Form 4 filings — Calhoun Lesley Ann
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 37,485 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 40,185 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 47,271 (derivative) @ $0 | EDGAR |
| 2024-09-06 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 10,880 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 6,250 @ $0 · Sale (S): 5,000 @ $7.21 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 308,940 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | Aligos Therapeutics, Inc. (ALGS) | Disposition to issuer (D): 176,237 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 · Disposition to issuer (D): 26,250 (derivative) @ $0 · Grant/award (A): 51,833 (derivative) @ $0 · Grant/award (A): 74,998 (derivative) @ $0 · Grant/award (A): 18,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1730866 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →